This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Purpose A “single time point” strategy for predicting the area under the concentration–time curve (AUC) for lopinavir in patients receiving ritonavir-boosted lopinavir therapy was investigated.
Methods Linear regression equations describing the relationships of lopinavir peak and trough concentrations to lopinavir AUC values were established using pharmacokinetic data from published studies of patients or healthy subjects receiving lopinavir and ritonavir at standard dosages. The resulting “trough–AUC model” and “peak–AUC model” were used to predict lopinavir AUC values in the evaluated study populations (total n = 479); those values were then compared with reported AUC values.
Results Lopinavir peak or trough concentrations were strongly correlated with lopinavir AUC values (r = 0.9947 and r = 0.9541, respectively). For about 94% of calculations using the peak–AUC model and 87% of calculations using the trough–AUC model, differences between predicted and observed AUC values were in the range of 0.76–1.5 fold; the associated r values were 0.9514 (p < 0.001) and 0.9345 (p < 0.001), respectively. The mean absolute predictive error was less than 6% with the use of either the peak–AUC model or the trough–AUC model, with corresponding values for root-mean-square error of 17.6% and 23.5%, respectively.
Conclusion Equations incorporating lopinavir peak and trough concentrations were found to satisfactorily predict lopinavir AUC values in data sets describing patients receiving lopinavir with ritonavir boosting. Variability in predictions was higher with use of the trough–AUC model.
- Copyright © 2016 by the American Society of Health-System Pharmacists, Inc. All rights reserved.
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
ASHP Members and Subscribers:
If you already have a subscription, you may gain access using your ASHP username and password.